XM does not provide services to residents of the United States of America.

Japan's Nikkei trades 1% higher after sharp drop

<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Japan's Nikkei trades 1% higher after sharp drop</title></head><body>

TOKYO, June 18 (Reuters) -Japan's Nikkei share average rebounded and gained 1% on Tuesday, as investors bought back stocks following the index's sharp loss in the previous session.

The Nikkei .N225 was up 1.05% to 38,504.11 by the midday break. The index ended 1.8% lower on Monday, slipping below the psychologically key 38,000 level for the first time this month.

The broader Topix .TOPX was up 0.74% at 2,719.92.

"The Nikkei fell more than it should have in the previous session, so investors bought back stocks," said Seiichi Suzuki, chief equity market analyst at Tokai Tokyo Intelligence Laboratory.

"But the market does see any good news to lift the index further or bad news to push it lower at the moment."

Chip-making equipment maker Tokyo Electron 8035.T rose 2.41% to provide the biggest boost to the Nikkei. Electronic parts maker TDK 6762.T jumped 7.22%.

Uncertainties about the Bank of Japan's policy path weighs on investor sentiment, limiting the Nikkei's advance, strategists said.

At its policy meeting on Friday, the BOJ said it would start trimming its bond purchases and also announce a detailed plan in July on reducing its nearly $5 trillion balance sheet.

"How much the BOJ will reduce the bond buying amounts will remain unclear until the next policy meeting and the market does not like to have uncertainties," Suzuki said.

The BOJ maintained its short-term policy rate target in a range of 0-0.1%, as expected.

"I do not think the BOJ can raise rates as early next month, as macro data won't not justify the rate hike," said Naoki Fujiwara, senior general manager at Shinkin Asset Management.

Of the 225 Nikkei components, 173 stocks rose and 51 fell, with one flat.

The pharmaceuticals sector .IPHAM.T lost 0.95% to become the worst performer among the Tokyo Stock Exchange's 33 industry sub-indexes.

Reporting by Junko Fujita; Editing by Rashmi Aich


Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.